质母细胞瘤中的信号通路
Isabella Gomes1, Renato José da Silva Oliveira2, Ana Paula Girol3
1Department of Biology, Post Graduate Program in Biosciences, Institute of Biosciences, Humanities and Exact Sciences (IBILCE), São Paulo State University (UNESP), São José do Rio Preto, Brazil; Experimental and Clinical Research Center (CEPEC), Padre Albino University Center (UNIFIPA), Catanduva, SP, Brazil.
质母细胞瘤 (GBM) 是一种致命的脑癌,结果不佳. 了解其遗传多样性是开发个性化治疗和改善患者存活率的关键.
科学领域:
- 神经瘤学神经瘤学
- 癌症遗传学 癌症遗传学
- 分子病理学分子病理学
背景情况:
- 质母细胞瘤 (GBM) 是最常见和最具攻击性的中枢神经系统 (CNS) 恶性瘤.
- 尽管采用标准治疗方法,但GBM患者的预后不佳,复发率高,存活时间有限.
- 自2016年以来,世界卫生组织 (WHO) 已将分子生物标志物纳入GBM分类中.
研究的目的:
- 审查GBM的流行病学和分类.
- 探索基因变异及其对信号通路的影响,这对于瘤发生,治疗反应和预后至关重要.
- 突出了解GBM的遗传和表观遗传异质性对于新的治疗策略的重要性.
主要方法:
- 文献综述侧重于流行病学,分类和GBM的遗传变化.
- 分析由遗传修饰驱动的信号通路变化.
- 对GBM病原和治疗影响的当前知识的综合.
主要成果:
- GBM表现出显著的遗传和表观遗传异质性.
- 特定的遗传变化影响瘤发生,治疗疗效和患者的治疗结果.
- 分子生物标志物对于分类GBM和指导治疗至关重要.
结论:
- 描述GBM的遗传环境对于理解其病变发生至关重要.
- 了解分子异质性可以为GBM患者提供个性化的治疗方法.
- 对遗传变化的进一步研究可以改善治疗策略和患者的生存率.
更多相关视频
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
相关概念视频
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
